Mysteries of CKD Care: Balancing Clarity and Uncertainty for Patient Engagement IN THIS ARTICLE, WE DELVE INTO THE PARADOXICAL CONCEPT OF USING UNCERTAINTY AS A DESIGN ELEMENT, ILLUSTRATING HOW IT CAN BE HARNESSED EFFECTIVELY TO ENHANCE PATIENT ENGAGEMENT WITHOUT COMPROMISING THE CLARITY AND PRECISION OF MEDICAL INFORMATION. November 28, 2023 INTRODUCTION Nephrologists and clinicians, social workers, nurses, and psychologists all
Summary At Ayogo, we harness Generative Large Language Models like GPT-4 to enhance patient experiences and relationships, and aid in crucial treatment decisions. Our aim? To combine top-tier technology with the empathy central to exceptional healthcare. We invite your insights as we pave the way for a tech-driven future that celebrates human compassion. Preamble In our rapidly advancing world, Generative
Part 2 – Interview with Jessica Dorazio, Product Designer at Ayogo: Check out Part 1 here! M: So today we’re discussing how a smartphone can fight harms to the health and wellbeing of vulnerable populations. What is it that you find particularly interesting about this topic? J: One reason I’m interested in this topic is I think I’ve increasingly grown
Interview with Jessica Dorazio, Product Designer at Ayogo: “Meet an Ayogi!” Welcome back to our ‘Meet an Ayogi’ series, where we spotlight the talented and diverse individuals that make Ayogo thrive! Today, we’re thrilled to introduce you to Jessica Dorazio, whose journey from business development leadership to product design at Ayogo is nothing short of inspiring. This interview was conducted
April is Celebrate Diversity Month, something we’d like to take a moment to reflect on. Ayogo’s Justice, Equality, Diversity and Inclusion (JEDI) committee was formally established in 2021. In truth, Ayogo has always championed a culture of inclusivity and diversity, but forming the committee was our way of further committing to our values and choosing to actively work towards achieving our
Ayogo CEO Michael Fergusson hosted a panel of passionate thought leaders at the Clinically Validated DTx Summit in December 2022. In the second clip from that panel, Edouard Gasser and Alexandra T. Greenhill, MD discuss the challenging path doctors and DTx developers must navigate together when designing and producing digital therapeutics.
Ayogo’s CEO Michael Fergusson hosted a panel of passionate thought leaders at The Clinically Validated DTx Summit in December 2022. In this excerpt, he and Sylvain Moreno of Digital Health Circle share their insights on bringing multiple stakeholders from government and academia together to create value.
Ayogo CEO Michael Fergusson hosted a panel of passionate thought leaders at the Clinically Validated DTx Summit in December 2022. In the final clip from that panel, Michael shares his perspective on the challenges that developers from traditional software backgrounds face when transitioning into the healthcare sphere.
Ayogo believes that creating effective digital healthcare solutions for patients with chronic kidney disease is possible. So we joined our expertise with Digital Health Circle to deploy a product that helps support patients and clinicians. Our product helps patients with kidney failure make educated decisions on treatment options.
CKD&Me fills the gap in pre-dialysis education by providing objective kidney care content U.S. pilot of CKD&Me will supplement patient education in several U.S. nephrology practices CKD&Me tailors its content for individual patient needs, covering physiology, treatment options, lifestyle factors in a manner that is easy to understand Baxter innovation supporting patients across the continuum of care highlighted in 15
- Page 1 of 2